$26.280
+0.804 (+3.06%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
Should I Buy Braveheart Bio, Inc. Stock?
Braveheart Bio, Inc. is a good buy right now, especially considering the recent insider purchases and strong IPO performance. The stock closed at $27.44, which is significantly higher than the IPO price of $18, reflecting a $12 gain per share. Furthermore, the company's forward P/E is 0, indicating potential for future earnings growth as it progresses in its clinical trials.
BRVE stock price ended at $26.28 on Tuesday, after rising +3.06%
Braveheart Bio, Inc. (BRVE) last closed at $26.28, gaining +3.06%. These facts feed the 1-day and 1-week BRVE price prediction above.
Forecast Drivers
Braveheart Bio, Inc. (BRVE) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Seasonality
Bullish
Seasonality analysis for BRVE
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.